These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7554381)

  • 1. Chloroquine inhibits T cell proliferation by interfering with IL-2 production and responsiveness.
    Landewé RB; Miltenburg AM; Verdonk MJ; Verweij CL; Breedveld FC; Daha MR; Dijkmans BA
    Clin Exp Immunol; 1995 Oct; 102(1):144-51. PubMed ID: 7554381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent CD3-crosslinking down-regulates interleukin-2 responsiveness in interleukin-2-competent cloned T cells: the possible involvement of protein kinase C.
    Landewé RB; Dijkmans BA; Verdonk MJ; Breedveld FC; Daha MR; Miltenburg AM
    Scand J Immunol; 1996 Jul; 44(1):45-53. PubMed ID: 8693291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of interferon-gamma, interleukin-2 and interleukin-4 on cyclosporin-A-mediated inhibition of anti-CD3-induced T-lymphocyte proliferation.
    Fitzpatrick L; Kaiser M; Stewart BH; Hoskin DW
    Int J Immunopharmacol; 1994 Apr; 16(4):289-93. PubMed ID: 8045668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leflunomide, a novel immunosuppressive agent. The mechanism of inhibition of T cell proliferation.
    Chong AS; Finnegan A; Jiang X; Gebel H; Sankary HN; Foster P; Williams JW
    Transplantation; 1993 Jun; 55(6):1361-6. PubMed ID: 8390735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased cAMP and cAMP-dependent protein kinase activity mediate anti-CD2 induced suppression of anti-CD3-driven interleukin-2 production and CD25 expression.
    Lin J; Gettys TW; Qin L; Chavin KD; Yang Q; Ding Y; Punch JD; Bromberg JS
    Pathobiology; 1995; 63(4):175-87. PubMed ID: 8866788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine and chloroquine synergistically inhibit the interferon-gamma production by CD4 positive and CD8 positive synovial T cell clones derived from a patient with rheumatoid arthritis.
    Landewé RB; Miltenburg AM; Breedveld FC; Daha MR; Dijkmans BA
    J Rheumatol; 1992 Sep; 19(9):1353-7. PubMed ID: 1432999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of FK506 and other immunosuppressive anti-rheumatic agents on T cell activation mediated IL-6 and IgM production in vitro.
    Sakuma S; Kato Y; Nishigaki F; Magari K; Miyata S; Ohkubo Y; Goto T
    Int Immunopharmacol; 2001 Apr; 1(4):749-57. PubMed ID: 11357886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tepoxalin, a novel immunosuppressive agent with a different mechanism of action from cyclosporin A.
    Zhou L; Ritchie D; Wang EY; Barbone AG; Argentieri D; Lau CY
    J Immunol; 1994 Dec; 153(11):5026-37. PubMed ID: 7963563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual variability in cyclosporin A sensitivity: the assessment of functional measures on CD28-mediated costimulation of human whole blood T lymphocytes.
    Härtel C; Hammers HJ; Schlenke P; Fricke L; Schumacher N; Kirchner H; Müller-Steinhardt M
    J Interferon Cytokine Res; 2003 Feb; 23(2):91-9. PubMed ID: 12744774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-CD3 antibody-induced expression of both p55 and p75 chains of the high affinity interleukin-2 receptor on human T lymphocytes is inhibited by cyclosporin A.
    Foxwell BM; Simon J; Herrero JJ; Taylor D; Woerly G; Cantrell D; Ryffel B
    Immunology; 1990 Jan; 69(1):104-9. PubMed ID: 2312149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human interleukin-10 can directly inhibit T-cell growth.
    Taga K; Mostowski H; Tosato G
    Blood; 1993 Jun; 81(11):2964-71. PubMed ID: 8499633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prodigiosin blocks T cell activation by inhibiting interleukin-2Ralpha expression and delays progression of autoimmune diabetes and collagen-induced arthritis.
    Han SB; Park SH; Jeon YJ; Kim YK; Kim HM; Yang KH
    J Pharmacol Exp Ther; 2001 Nov; 299(2):415-25. PubMed ID: 11602650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous cross-linking of CD6 and CD28 induces cell proliferation in resting T cells.
    Osorio LM; Rottenberg M; Jondal M; Chow SC
    Immunology; 1998 Mar; 93(3):358-65. PubMed ID: 9640246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporin A inhibits the early phase of NF-kappaB/RelA activation induced by CD28 costimulatory signaling to reduce the IL-2 expression in human peripheral T cells.
    Nishiyama S; Manabe N; Kubota Y; Ohnishi H; Kitanaka A; Tokuda M; Taminato T; Ishida T; Takahara J; Tanaka T
    Int Immunopharmacol; 2005 Apr; 5(4):699-710. PubMed ID: 15710339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cyclosporin A on IL-2 production and lymphocyte proliferation during infection of mice with lymphocytic choriomeningitis virus.
    Kasaian MT; Biron CA
    J Immunol; 1990 Jan; 144(1):299-306. PubMed ID: 1967265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
    de Waal Malefyt R; Yssel H; de Vries JE
    J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression.
    Chouaib S; Welte K; Mertelsmann R; Dupont B
    J Immunol; 1985 Aug; 135(2):1172-9. PubMed ID: 2989362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FK506 potently inhibits T cell activation induced TNF-alpha and IL-1beta production in vitro by human peripheral blood mononuclear cells.
    Sakuma S; Kato Y; Nishigaki F; Sasakawa T; Magari K; Miyata S; Ohkubo Y; Goto T
    Br J Pharmacol; 2000 Aug; 130(7):1655-63. PubMed ID: 10928971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporin A inhibits T cell receptor-induced interleukin-2 synthesis of human T lymphocytes by selectively preventing a transmembrane signal transduction pathway leading to sustained activation of a protein kinase C isoenzyme, protein kinase C-beta.
    Szamel M; Bartels F; Resch K
    Eur J Immunol; 1993 Dec; 23(12):3072-81. PubMed ID: 8258320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional properties of the 50 kd protein associated with the E-receptor on human T lymphocytes: suppression of IL 2 production by anti-p50 monoclonal antibodies.
    Tadmori W; Reed JC; Nowell PC; Kamoun M
    J Immunol; 1985 Mar; 134(3):1709-16. PubMed ID: 2981919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.